This morning, we reported third quarter revenues of $266 million, adjusted pre-tax income of $54 million, and adjusted EPS of $0.96 per share. For the nine-month period, we had record revenues of $746 million, adjusted pre-tax income of $159 million, and adjusted EPS of $2.84 per share. Before we review our results in more detail, I wanted to make a few comments on the broader operating environment. We have previously spoken about an increasingly challenging macro environment. As the year has progressed, hopes of a soft landing have grown increasingly less likely, as successive rate hikes have failed to stem the inflationary tide. Clearly, the Fed will need to go further and push rates higher than previously thought. This, in turn, has increased the probability of an economic contraction next year. At the same time, further disruptions caused by the war in Ukraine, rising energy prices, and political instability are pressuring markets and economies in Europe and elsewhere around the globe. Notwithstanding these significant headwinds, each of our businesses continues to perform well, with higher revenues in both the three and nine-month periods compared to a year ago. After Helen takes you through our financial results, I will review our business performance and outlook in greater detail. Helen? Thank you, Paul. Good morning. Beginning with revenues. Total revenues for the third quarter were $266 million, up 15% year-over-year, driven by meaningful growth in both strategic advisory and restructuring revenues and a slight increase in PJT Park Hill revenues. Interest income and other revenue decreased to $0.5 million in the third quarter. For the nine months ended September 30, total revenues were $746 million, up 10% year-over-year, with significant revenue increases in restructuring and PJT Park Hill and a modest increase in strategic advisory revenues compared to the prior year. Interest income and other revenue decreased $7.6 million in the nine-month period. Excluding interest income and other, total revenues for the nine months were up 11% year-over-year. Turning to expenses. Consistent with prior quarters, we presented the expenses with certain non-GAAP adjustments. These adjustments are more fully described in our 8-K. First, adjusted compensation expense. Our compensation accrual for the first nine months of the year was 64% of revenues. We increased the year-to-date compensation ratio from 63%- 64% due to increased uncertainty resulting from the current operating environment. Given we had accrued compensation at 63% through the first six months of the year, the resulting comp was accrued at 65.8% in the third quarter to bring our nine-month ratio up to 64%, which is our current best estimate for the year. Turning to adjusted non-compensation expense. Total adjusted non-compensation expense was $37 million for the third quarter, up $4 million year-over-year, $109 million for the nine months, up $16 million year-over-year. As a percentage of revenues, this represents 13.9% in the third quarter and 14.6% for the first nine months. Of the $16 million year-over-year increase in non-comp expense for the first nine months of the year, approximately $12 million was due to increased travel and related expense. For the full year, we continue to expect our non-comp expense, excluding travel and related, to grow in the high single-digit percentages, driven principally by increased client and internal events, increases in senior advisor expense, as well as a modest expansion of office space. Turning to adjusted pre-tax income. We reported adjusted pre-tax income of $54 million for the third quarter and $159 million for the first nine months. Our adjusted pre-tax margin was 20.3% for the third quarter and 21.4% for the first nine months. The provision for taxes, as with prior years, we've presented our results as if all partnership units had been converted to shares and that all of our income was taxed at a corporate tax rate. Our effective tax rate for the first nine months of 2022 was 25.8%, and we expect this to be our effective tax rate for the full year. Our adjusted if converted earnings were $0.96 per share for the third quarter and $2.84 per share for the first nine months. On a per share basis for the quarter, our weighted average share count was 41.5 million shares. During the third quarter, we repurchased the equivalent of approximately 279,000 shares, primarily through open market repurchases, bringing our repurchases in the first nine months to approximately 2 million shares, including the exchange of partnership units for cash. On the balance sheet, we ended the quarter with $290 million in cash equivalents, and short-term investments, and $293 million in net working capital, and we have no funded debt outstanding. Finally, the board has approved a dividend of $0.25 per share. The dividend will be paid on December 21, 2022 to Class A common shareholders of record as of December 7. With that, I'll turn it back to Paul. Thank you, Helen. In Strategic Advisory, despite the volatile operating environment, many of the leading indicators we track remain positive. Our mandate count is at near record levels as our clients remain highly engaged on matters of strategic importance. Our addressable market continues to grow as our coverage footprint expands. Following the COVID sequestration, our bankers are back traveling, crisscrossing the globe to be with clients. This greater degree of in-person engagement fundamentally plays to our strengths. It showcases our differentiated capabilities and collaborative culture, and better positions us to cultivate new relationships as well as strengthening existing ones. On an industry-wide basis, while clients' willingness to engage in strategic dialogues remains high, converting mandates into announcements has become increasingly difficult. In the U.S. and globally, industry-wide M&A announcement volumes have fallen sharply from year ago levels. Many announced transactions are taking longer to close with an increasing number of terminated deals. Amidst this turbulence, we continue to perform well on a relative basis as clients increasingly recognize our integrated holistic approach to advice. Although we delivered record strategic advisory revenues for the nine-month period, given deals pushed out and deals withdrawn, we no longer expect our full year strategic advisory revenues to exceed last year's record levels. Our strategic advisory partner count has grown 18% from year-end 2021. We see this environment as a particularly opportune one to invest in and have stepped up our senior recruiting efforts as a result. Turning to restructuring. Rising interest rates, inflationary trends, supply chain pressures, and less accommodating capital markets are pressuring companies' balance sheets and their access to funding. As the year has progressed, our restructuring business has become increasingly active with an uptick in mandates compared to a year ago levels. Our restructuring revenues are up for both the three-month and nine-month periods relative to a year ago. As we have spoken about previously, the close partnership between our restructuring bankers and our expanding roster of strategic advisory bankers has increasingly enabled us to present our integrated and differentiated liability management capabilities to companies at the first signs of distress. Not surprisingly, our firm has maintained its leadership position in restructuring and liability management. For the first half of 2022, the most recent period for which we have published rankings, we ranked first in number of announced restructurings in the U.S. and second globally. In PJT Park Hill, after a red-hot fundraising environment in 2021, market conditions have softened as asset allocators feel the sting of price declines across their investment portfolios. With fewer M&A monetizations, dividend recapitalizations, and IPOs, the pace of capital return to LP investors has slowed considerably. As a result, both LPs and GPs are looking for alternative ways to create liquidity in their portfolios. Against this backdrop, PJT Park Hill delivered record nine month revenues and remains on track to deliver record full-year results. As we look ahead, the current operating environment is impacting each of our businesses in different ways. While these market conditions have been positive for our restructuring business, they have negatively impacted our strategic advisory business. In PJT Park Hill, the effects have been more nuanced, with unsettled markets dampening our primary businesses while benefiting our secondary businesses. In difficult environments such as these, our differentiated business model more clearly shines through. We remain confident that our diverse mix of integrated businesses positions us well on both an absolute and relative basis. We have the right people, the right capabilities, and the right culture to not only weather this challenging environment, but to emerge stronger on the other side. With that, we will now take your questions. If you would like to ask a question, please signal by pressing star one on your telephone keypad. Please ensure that the mute function on your telephone is switched off to allow your signal to reach our equipment. Again, it is star one to ask a question. The first question today comes from the line of Devin Ryan of JMP Securities. Thanks. Good morning, everyone. Good morning, Devin. Good morning. Thanks for all the details. I guess just want to start on the financing markets and interplay with what you're seeing in Strategic Advisory and maybe some of the outlook commentary. Obviously, financing markets hit a little bit of a rough patch in the third quarter, and Fed funds and rates are just more broadly still expected to move higher, as you mentioned. The borrowing costs are higher. Can you talk a little bit about how that's impacting, you know, both the friction in the market and higher borrowing costs, activity in Strategic Advisory and your outlook for both sponsors and corporates? Sure. I think on the side, it's pretty clear you've got a micro and a macro pressure. I think on a micro level, there's you know, less quantum of debt available, you know, from a financing perspective for most assets. The cost of that debt has gone up. When you pencil out rates of return, clearly you're getting to lower valuations because there's less leverage, and the leverage that is part of the financing structure is more expensive. That clearly has an effect on valuations, which until the market fully adjusts and there's a reset, that creates a headwind. I think you have a second issue, which is an awful lot of capital has been put out by financial sponsors in a relatively short period of time. Probably the vast majority of those investments are, you know, worth in the current spot market, you know, the same or less than when they, you know, agreed to those transactions. I think there's a, you know, a second order, which is until there's, you know, greater clarity as to, you know, where markets are gonna settle out at and whether or not there's potentially another leg down, there's probably gonna be a, you know, a less aggressive push to put capital out. We see sponsors being less active in the near term. I think that presents itself in the data, but it's also very clear anecdotally. That's not a permanent phenomenon. That's sort of a transitory phenomenon. If sponsors were overly active, you know, in 2021, they're probably, you know, correcting, you know, to the downside, and you're seeing that significant deceleration in activity. I think, you know, over time, as we get to a new normal, as we get to some equilibrium in terms of financing and cost of capital and prices, you'll start to see that activity pick up. Then I think you also have another phenomenon, which is you have, you know, the balance sheets clogged to some extent with a number of banks holding significant inventories of committed but not syndicated financings. Until that works its way through, I think all else equal, while there'll be transactions, probably that pressures the market for larger size commitments a bit. Inevitably, all of this works its way through the system. Yep. Okay. Thanks for all the detail there. Want to follow up just on the strong growth in employee headcount. It was up 9% in the third quarter from the end of the second quarter. You know, it seems like you're still very much leaning in on growth. You talked about kind of accelerating senior banker recruiting as well. I'm curious, was this big step up just kind of timing dynamic and just catching up to support the existing firm, or was this getting a little bit ahead of some of the senior recruiting that you're going to be doing? Just taking all together, I'm assuming this isn't battening down the hatches and you know, obviously, you know, people are starting to talk about letting people go. It feels like you guys are going the opposite direction. Just want to maybe dig in a little bit more on that and then thought process on the big step up. Yeah. I think you need to be careful when you go from the second quarter to the third quarter. You get all the campus recruiting and all of the analysts and associates that show up. If you look at it quarter to quarter, you really need to look at that, you know, year over year and, you know, the full year, because that's when, you know, a disproportionate amount of our junior recruiting shows up in the headcount because they all arrive in the third quarter. That's not representative of full year growth. You can't take that and annualize it. You know, we have slowed our overall headcount a smidge. It's literally a smidge. I think that's a technical financial term, a smidge, relative to last year. What we said previously was, in this environment, we were going to be most focused on hiring at the most senior levels. If transaction activity and velocity slowed a little bit, we needed less incremental headcount to support that. That's probably what you'll see as we, you know, continue to move into 2023. We feel that this is, you know, a very attractive environment for us. I have spoken repeatedly about the double whammy that we faced in recruiting in 2021. One was when you're on lockdown and people are working remotely and they're not in the office, it's difficult to really vet candidates, for candidates to understand just how special a place PJT is. As the world has, you know, returned to a greater sense of normalcy, not surprisingly, our recruiting has picked up. I've also spoken about how when you're at breakneck pace transaction activity, as we were in 2021, it's very difficult to recruit because everyone is so busy and it's hard to get mind share, but also the friction with a senior hire leaving all of their client mandates, you know, behind and leaving their clients in the lurch is compounded. In a lower transaction velocity environment as we're in, we're having more of those conversations. There's, you know, greater take-up, and there's more comfort in making a senior move because the friction cost is meaningfully less. We talked about all of the headwinds that in 2021. Most of those, you know, have dissipated, and now we've got some tailwinds blowing. I would expect us to capitalize on that at the senior level, where the major focus will be, and less so in terms of, you know, the infrastructure to support that. You're focused on the campus effects in Q3. Yeah. Yep. Okay. Got it. Thanks for all the color. I'll hop back in the queue. Okay. Thanks, Devin. Good to speak. The next question comes from, Richard Ramsden of Goldman Sachs. Hey, good morning, everyone. Paul, can you just help us think through the increase in the comp to revenue ratio? It sounds like on one hand you said, you know, this is partly because of the uncertainty in the operating environment, but it also does sound like you are accelerating investments too. It'd be helpful if you could just unpack the two. Then on the investment side, how long do you think this would persist for? Is this something that you think is really just gonna impact this year, or do you think it could continue into next year as well? Yeah. Well, let's kind of put this in perspective. We made our first comp accrual for the year, which was our best estimate of the full year at the end of the first quarter. We're now looking at the world six months later. Just to give you some perspective, you know, if you break up this year into roughly two five month periods, you know, transaction activity was down about 20% in the first five months and down about 50% in the second five months. Clearly a significant step down. What we're saying is, in light of all of the news flow, all of the dislocations, all of the pressure on announced transactions, and in light of our commitment to invest and strengthen and capitalize on the business, in light of all of that, our judgment is that as we're sitting here today, the appropriate full year comp to revenue ratio has moved 100 basis points. That's how we think about it. It needs to flow through at some point. What you're really seeing in the third quarter is the catch-up for the first and the second quarter, which is why it's more than 100 basis points in Q3. We're never smart enough to know with precision, you know, one-fourth of the way through the year what the right ratio is. I think just given, you know, a slowdown in transaction activity while recruiting remains robust, that the appropriate thing to do is to bump the full year accrual by 100 basis points. Okay, got it. Then secondly, look, I mean, it's probably too early to think about the outlook for 2023, but there's a lot of companies that have got significant financial obligations from a debt refinancing perspective heading into 2023, and there's a significant refinancing need. Obviously, as you talked about, debt markets have deteriorated, if anything. Look, should we think about that predominantly as a restructuring opportunity, or do you think, you know, the fact that debt markets are so dysfunctional could actually spur a pickup in M&A as we head into 2023? I think you could have both next year. If you said to me, where do I have the greatest clarity, it's that the Restructuring trend will continue to vector up into the right. I don't see any signs that that's gonna change. It's hard to imagine that, you know, with all that has transpired this year and all that has been set in motion, that that momentum, now that it's kinda, you know, running on the track, is not gonna, you know, lead to, you know, more, not less activity next year. It's not clear to me, though, that it pressures, you know, Strategic Advisory levels for a couple of reasons. One is when we, you know, close the books on 2022 in Strategic Advisory, this is going to be a very weak year, and therefore we're starting with a base level of activity where, you know, there may well be, you know, a lot of reasons to think that next year will be stronger. I also think that, you know, what we're dealing with here is just the massive, you know, move in financing rates, equity prices, uncertainty, and it's less the absolute conditions and more the rate of change. When you get everything into a new equilibrium, I think you have a clear base to build back up. I'm not ready to prognosticate for 2023, but I'm not at all ruling out that we couldn't have, you know, a step up in activity in 2023. I don't think you'll need that much of a catalyst to do that. If we just kind of step way back, you know, our view, which I think was out of consensus at the beginning of the year, was we saw the M&A market as being down. I don't know if I ever, you know, publicly quantified it. I think in our minds we were thinking, you know, down 10%-15%. For the first five months of the year, you know, it was down 20%. There's no doubt that we're in a, you know, an air pocket where, as rates keep moving, as inflation continues to spiral, with all of the second and third order consequences of the war in Ukraine and energy prices and supply chain and political uncertainty and market dislocations, you know, activity has slowed appreciably. As I said before, it's running about 50% in the second five months of the year, you know, behind. I don't see that persisting, but we need to kinda get to a new equilibrium. That could happen very soon or it may take a little bit of time. I don't think that the current level of activity is representative of the new normal. It may be a temporary normal, but it's not the new normal. Okay. All right. Thank you. That's very helpful. Our next question comes from Steven Chubak of Wolfe Research. Hey, good morning. Good morning. Sorry to beat a dead horse here, Paul, but I'm gonna press you a little bit more on the comp ratio. Okay, go for it. Looking out to next year, you know, it sounds like RX fees or restructuring fees are likely to be a much higher contributor in 2023, just given the timing of when those success fees will ultimately hit. From what it sounds like, given you're coming into this quarter with a strong backlog and you gave pretty subdued or conservative advisory revenue guidance with the strong mandates, it does suggest that you're likely to enter 2023 with a very strong backlog as well, with some of the delayed closings. Do you see a credible path to growing revenues next year? How should we think about the comp accrual, assuming a better revenue backdrop? Yeah. Well, again, forgive me for punting a little bit. I'm more than happy to give you a full year perspective. At the beginning of the year when we actually all kind of baseline is because, you know, 2022 is done and dusted. What's kinda hard to do is, without knowing what actually hits in the fourth quarter of 2022 and what gets pushed as backlog into next year, and without knowing sort of, you know, what the pace of announcements and mandates is for the next two and a half months, it's, I think we run the risk of confusing each other by talking too much about sort of next year. If you said to me though, you know, on the bullish, bearish meter, how am I thinking about the businesses, I would say the following: I think restructuring is clearly, based on everything we see today, that locomotive heading down the train tracks, to use that visual, that's in all likelihood only gonna pick up speed. I see that as, you know, an incremental tailwind in 2023. I think Park Hill is gonna have its puts and takes next year. I think clearly the fundraising environment is more challenging. There's less liquidity and monetizations for LPs. They have these oversized commitments. I think they're gonna be more discriminating. I think fundraising is gonna be more difficult. I think fewer companies, as we've sort of foreshadowed in prior commentaries, are finding it harder and harder to reach, you know, their full fundraise. But at the same time, if you're not getting liquidity from the underlying assets, you're gonna see more activity amongst LPs in looking to create liquidity by selling their stakes in GPs. You're gonna see more GPs trying to do monetizations through the, you know, GP solutions capabilities. So that one is gonna be pushes and pulls and, you know, we'll see where that all nets out next year. But I think the fundraising environment is going to be more challenging. There's no doubt about that. In Strategic Advisory, we've always talked about ourselves as being idiosyncratic. It's just very hard if the market is down 50% to outrun 50% through market share gains. At some point, you know, if the market, you know, is in extremis, I just don't believe that that's where we're headed to next year because I suspect that, you know, we will get to, you know, a point of exhaustion on rates. We'll get to a point where there is, you know, greater clarity, where banks will return to, you know, more forward leaning lending commitments, where private equity having, you know, paused for some considerable period of time will, you know, return to put significant amounts of capital out, where strategics have seen some of their strategic ambitions, you know, put on hold as long as we get a little bit more clarity and less volatility in the market. That's sort of where my gut is, but I just think it's a little hard to roll it all up until we go and we're done and dusted on 2022. But I think there is the most clarity of all is in Restructuring. I do think that there's a reasonable, you know, prospect of Restructuring and Strategic Advisory both moving forward next year. That's really helpful, Paul. Just for my follow-up, a clarifying question just on the full year advisory revenue guidance. Admittedly, your indication that's gonna be down full year 2022 versus 2021 certainly implies a rather challenging outcome for the fourth quarter. Wanna better understand what's driving it. Is it simply a function of delays, which should like and like, do you expect any of those deals to fall out, or any perspective that you can give in terms of what's driving some of the pressures in what's typically a very seasonally strong quarter, not just for you, but for the group more broadly? Yeah. Again, there's a lot in that where you mixed in seasonal with annual, with advisory, with our firm-wide numbers. Let me try and unpack that a little bit. The fourth quarter is traditionally seasonally strong. I don't think I've said anything to that the fourth quarter won't be seasonally strong. Let's just take that one and move it to the side. Then there's the second one, which is, I think I said in my comments that because we have seen a number of announced deals withdrawn, and that's all part of the public record, and there are probably other announced deals that may take longer to close, i.e. fall into 2023, that tied to those factors, we no longer see ourselves setting another record, in that one business of which we have three businesses. Then. You did. Go ahead. You did indicate that advisory revenues would be down full year 2022 versus 2021. Strategic Advisory. Okay? I just wanna be clear of our three businesses. Okay. That's Strategic Advisory, that's not talking about Restructuring, that's not talking about Park Hill. Okay. I'm talking about it not the way. Thank you for the clarification. Yeah. That's why I said it's only one of three businesses. I did talk about the fact that Park Hill would have a record year this year. I did talk about the fact that restructuring would be up. Two of our three businesses will be up, and the third one will fall, you know, a smidge or more short because of the very specific factors. Certainly a good outcome for this environment. Thanks so much for taking my question, Paul. Thank you. Absolutely. Our next question is from Jim Mitchell of Seaport Global. Hey, good morning. Good morning. Paul, morning. Maybe we could just talk a little bit about the deals being withdrawn. I think that's, you know, been more of a last few months type phenomenon. Can you just sort of give us a sense, is that more the financial sponsors, you know, based on price or financing? Or is it strategics? How do we think about what's driving withdrawals and how do you see that playing out for the next few months? Look, it's like anything else. You know, when you have transactions taking long periods of time to close, and we've seen that phenomenon for a while, some of that is, you know, longer regulatory reviews. When markets are completely dislocated, in all likelihood, you know, a deal that was struck in a different time and era that was perfectly pitched between buyer and seller is no longer perfectly pitched between buyer and seller. Either the buyer, you know, has buyer's remorse or the seller has seller's remorse, but there is a binding commitment. Now, if things go long enough, you know, in some instances, not all, but in some instances, not even many, but in just, you know, there is an opportunity because some condition has not been met and you no longer have two motivated sides to a transaction. To me, it's really, it's the interplay of extended period of time between signing and receipt of all, you know, approvals and all conditions being satisfied. You know, one side or maybe both saying, "You know what? This deal made sense in that market environment. It doesn't make sense in this." Some of these are mutual consent because, you know, some of the reasons for a transaction no longer makes sense. In others, it may be that one side is, you know, seeing that, when you get to a termination period, rather than just automatically extending it, they're saying, "Gee, you know, we'd just as soon walk away." It's not dramatic, but it tends to spike some period of time after there's been a meaningful pivot in asset values up or down. If it's up, it tends to be the sellers. If it's down, it tends to be the buyers who are, you know, asking themselves. If it's just dislocated equity markets, sometimes it's by mutual agreement. It's a little bit of everything. There's no one culprit to it, but it's the final toll to pay when you have a meaningful, you know, revaluation up or down and dislocation in markets. Deals that were struck in a different time may not, in the fullness of time, you know, be as compelling. That affects everyone. Yep. It's different. Yep. And- Okay. Again, that's why I think this is all about kind of. This is like the turbulence until you kind of, you know, get up to a higher cruising altitude, and you can kinda get above it. I think we're, you know, almost all through that, and I would suspect that, you know, that's really not gonna be a forward-looking issue. That's more of a backward-looking issue. Okay, great. Just maybe on liability management within restructuring, how big would you say that business has become? I would imagine that has a shorter time or turnaround time in terms of completion. Are both those statements correct? Any way you could help us think through the impact of liability management? Yeah, absolutely. Look, I mean, clearly, you have a lot of companies who are sitting there saying, "Okay. Like, you know, my choke point may be out, you know, three years. So what can I do today to give myself more room? How can I position myself? Gee, my debt's trading at a significant, you know, at significantly dislocated prices. Can I take advantage of it? Is there a debt tender? Is there an exchange? Is there a tender with, you know, an amendment?" There's all of that dialogue, and this has really focused, you know, senior financial executives who have the responsibility of keeping their companies fully funded. As you look at walls of maturities, as you look at access to bank revolvers and the like, you need to make sure that, you know, you can always pass the stress test, and this is clearly a stress test. That has been a meaningful uptick in activity. You're also finding companies that, you know, have gotten to the end of the line, where they're gonna need to, you know, go through the court processes to deal with their over-leveraged situation. At some point it's gonna be both. Right now you're seeing a lot of, you know, increased activity on liability management. That's where having an ever-growing presence in Strategic Advisory and the coverage force, that's where it's a real benefit because those dialogues tend to be with trusted advisors and having those relationships. As we build that out, that's fueling some of our, you know, Restructuring success. Great. Thanks. Absolutely. Our next question comes from Mike Brown of KBW. Great. Hi, good morning. Hey, Mike. Good morning. I'm still just getting some questions here about some of your commentary for the full year. I was hoping to maybe just clarify your comment as it pertains to the fourth quarter. Appreciate the color on the strategic advisory for the full year and your comments on restructuring in the placement business. If I take all of that together and the, you know, the challenges of deals in terms of withdrawals and elongations of closing times, is it still fair to expect that the advisory fee line can be sequentially higher in the fourth quarter versus the third quarter? Again, just a lot of commentary there. I wanna make sure that I understand all the pieces correctly. Yeah. I mean, I wish I could wave a magic wand and make that advisory placement distinction go away because it's not really how we think about the business and how we manage the business. As we've talked about in advisory that we report, you have restructuring revenues, you have core strategic advisory revenues, and you have some Park Hill revenues. It's a little bit of everything. Let me come at this a little differently, and we're not giving fourth quarter guidance. I've simply made one comment, which is that our strategic advisory business, which is one of our businesses that is up for the nine months, will most likely not end the year up. We have two other businesses that, you know, are not included in that commentary. I think I've been pretty clear about their prospects. Sure. Okay, thank you. Then on the restructuring side, I was hoping to just hear a little bit more about the complexion of the mandates there in terms of what you're seeing by sector and by region, and what's some of the themes that are at play that's driving the increase in restructuring right now? When you look out to 2023, if I understand there's, you know, quite a lag in success fees, and it really depends on the type of transaction. Do you see those as more of a second half type of contribution for the year? Is it fair that it could start to be, you know, more consistent throughout the year? Look, these are steady builds, right? Because as you take on more assignments, you get more retainers. Then as things where we started to see an inflection point, you know, I think we started to get more constructive on restructuring late last year, would be my sense, right? Sort of late 2021. We just started to see that inflection. You know, as you start to get some tick up in mandates, those take, you know, some quarters to resolve themselves. You start to see some of those early wins starting to work their way through as you have more retainers. Clearly, like anything, it takes a while for that momentum to build. All else equal, you know, it's probably not, you know, a straight line, you know, equally apportioned quarter to quarter. It probably, you know, gets better as, you know, time, you know, marches on. I think that would be just a general direction about how restructuring will continue to feed into our results, you know, for the rest of this year and into next year, probably, you know, more time, better results. I think we're seeing all sorts of situations in a broad array of industries, and there's a lot of different catalysts. I think some of this is you have, as I've spoken about repeatedly, you had companies that were severely damaged by COVID. It all was covered up by, you know, extraordinarily, you know, accommodative fiscal and monetary policy and near zero interest rates. You know, you take that punchbowl away, some of the lasting damage and, you know, some of the buying behaviors that existed in that, you know, retreat to back to normal. All of a sudden, a lot of those companies find that, you know, they don't have the balance sheet to enable them to operate their businesses. That's a theme. You have another theme of companies who have a lot of floating rate debt, and all of a sudden, you know, as the rates move up. You have others who are dealing where there's a mismatch in currency, and the wild swings in currencies have created a stress there. You're dealing with companies who are operating on relatively thin margins, and now you're dealing with supply chain delays and dislocations, and you can't get, you know, product to the end user, and you can't get revenues booked, but you've got all this expense. You've got just idiosyncratic situations in various companies that, you know, create issues. You know, management decisions that have, you know, not worked out well or litigation overhang or the like. It's just about everywhere. I would also say that activity levels in Europe tend to lag. Now as we get a little bit more into this credit cycle, we're starting to see, you know, more and more activity. As we've continued to build out our, you know, coverage footprint in Europe, we're able to capitalize on more of that. It should come as no surprise that, you know, the Asian opportunity has, you know, ticked up just given, you know, all that has gone on in that part of the world. It's not one thing. It's almost everything starting to just turn a little bit, and I don't really expect that to change in the foreseeable future. I think that this is kind of the next wave we're in now. Some of that's a function that we were in just unnaturally benign markets before, and you can argue that we're just going from, you know, the abnormal as far as near zero rates, risk on plentiful capital, record equity prices, et cetera, to, you know, more of a normal. I think it's beyond that, and I suspect that there's real structural challenges for lots of companies and lots of industries around the globe. We'll present ourselves to try and help companies be proactive where we can, hence more and more focus on liability management. There'll be other situations where working through, you know, the restructuring processes will be more appropriate. Very interesting. Thank you for taking the questions, Paul. Absolutely. That was our final question. We will now turn back to Paul J. Taubman for his closing remarks. Wonderful. Well, again, we very much appreciate everyone's interest in our company. Thank you for your questions. Thank you for your time this morning, and we look forward to speaking with you again when we report full year results in early 2023. Thank you.